Article

Eye Tracking Useful in TBI Treatment

Many patients with traumatic brain injury (TBI) also suffer from negatively altered motor functions and communication behaviors, according to lead author Lorene Leung. The study will be presented in a poster session on Apr. 18 at the American Academy of Neurology meeting in Washington, DC.

Many patients with traumatic brain injury (TBI) also suffer from negatively altered motor functions and communication behaviors, according to lead author Lorene Leung. The study will be presented in a poster session on Apr. 18 at the American Academy of Neurology meeting in Washington, DC.

Since TBI is often accompanied by other side effects, and therefore can cause misdiagnoses, Leung and colleagues used gaze monitoring to examine eye tracking responses.

The team gathered 3 males who were diagnosed with being in a post-traumatic confusional state. Recruited from an acute rehabilitation hospital, the patients had their eye movements recorded with a visual cognition fMRI study.

The non-verbal, motor-free approach aimed to find the most reliable way of judging eye gaze responses when it came to communication as well as following commands.

“Monitoring the longest period of eye gaze during stimulus presentation appears to be the most reliable way to determine eye gaze responses in patients with severe TBI,” the authors concluded.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.